Back by
popular demand, the 2019 industry heatmap provides a high level overview
of the latest developments in the European novel therapy manufacturing space
across The United Kingdom, Belgium, Greece and Switzerland, among others.
With the
2018 commercialisation of prominent Autologous therapies such as KITEs Yskarta
and Novartis’ Kymriah in the global market, more and more companies are
beginning to move towards commercially based products. Yet despite these
unquestionable industry growths, challenging issues can hinder – and even halt
– groundbreaking progress in its tracks. There are still no established routes to
market and with continuous changes in regulatory requirements across
different global markets achieving any form of standardisation is
difficult.
Download this free resource to gain valuable insights on some of the biggest challenges:
Joining
this year’s curated programme will take you through a series of sessions from
translation and collaboration to ensuring GMP compliance and optimising
scalability. This year’s forum is also your one-stop shop for:
To find out more information on the sessions, download the full agenda of the conference here. To request a copy to be sent via email, please click here.
Please note: That all fields marked with an asterisk (*) are required.